This report also showed that Copine 3 expression is increased significantly in metastatic prostate cancer compared with normal prostate and nonmetastatic tumors and in ovarian endometrioid carcinomas compared with normal ovarian tissues. This evidence concerns the gene CPNE3 and metastatic prostate carcinoma.